NEOGENOMICS INC's ticker is and the CUSIP is 64049MAB6. A total of 37 filers reported holding NEOGENOMICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,521,826 | -1.8% | 4,900,000 | 0.0% | 0.01% | 0.0% |
| Q2 2023 | $3,586,898 | -0.7% | 4,900,000 | 0.0% | 0.01% | 0.0% |
| Q1 2023 | $3,611,398 | +14.7% | 4,900,000 | 0.0% | 0.01% | +9.1% |
| Q4 2022 | $3,148,887 | -50.3% | 4,900,000 | -50.0% | 0.01% | -8.3% |
| Q3 2022 | $6,333,919 | +3.7% | 9,800,000 | 0.0% | 0.01% | +9.1% |
| Q2 2022 | $6,110,003 | -6.5% | 9,800,000 | 0.0% | 0.01% | +22.2% |
| Q1 2022 | $6,537,741 | +56.2% | 9,800,000 | +100.0% | 0.01% | -18.2% |
| Q4 2021 | $4,185,000 | -29.7% | 4,900,000 | -16.9% | 0.01% | -35.3% |
| Q3 2021 | $5,954,000 | -48.7% | 5,900,000 | -50.0% | 0.02% | 0.0% |
| Q2 2021 | $11,596,000 | +93.8% | 11,800,000 | +100.0% | 0.02% | -5.6% |
| Q1 2021 | $5,983,000 | – | 5,900,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ZAZOVE ASSOCIATES LLC | 5,915,000 | $5,997,000 | 0.52% |
| LINDEN ADVISORS LP | 85,665,000 | $86,557,000 | 0.51% |
| SSI INVESTMENT MANAGEMENT LLC | 5,629,000 | $5,688,000 | 0.34% |
| Nicholas Investment Partners, LP | 4,620,000 | $4,672,000 | 0.34% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 15,205,000 | $15,402,000 | 0.28% |
| Calamos Advisors LLC | 53,591,000 | $54,018,000 | 0.24% |
| AQR Arbitrage LLC | 4,125,000 | $4,192,000 | 0.12% |
| CAMDEN ASSET MANAGEMENT L P /CA | 2,075,000 | $2,098,000 | 0.08% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,500,000 | $2,514,000 | 0.05% |
| WOLVERINE ASSET MANAGEMENT LLC | 5,645,000 | $5,715,000 | 0.05% |